Proactive Investors - Run By Investors For Investors

Genus gets first results in US cattle sexing case

The technology is important because there's a big market for dairy farmers, which want female calves (to produce milk).
Genus gets first results in US cattle sexing case
Mooving on - the first decisions are out from the court in Wisconsin

Genus plc (LON: GNS) is awaiting US court rulings concerning its GSS technology for sexing cattle semen.

The technology is important because there's a big market for dairy farmers, which want female calves (to produce milk).

A commercial launch of GSS product would increase competition in the market for the processing of sexed bovine semen and that's what's really at the heart of the court case in Wisconsin.

At the trial yesterday, the jury found that Genus and its firm ABS had proved that Inguran LLC, operating then as Sexing Technologies (ST), had maintained monopoly power in the market for sexed bovine semen processing in the US since July 2012.

But the jury also found that Genus had not proved that it had suffered injury as a result.

But the case is not over. The jury still has to consider ST's counter claims related to two of its US patents and ST's counter claims that Genus breached confidentiality obligations under the 2012 semen sorting agreement between the parties and it will also consider, if applicable, a verdict on damages in relation to these matters later this week.

View full GNS profile View Profile

Genus Timeline

Newswire
February 16 2015

Related Articles

1537236236_main-better-use.jpg
September 18 2018
The company is utilising technology and big data to tackle the growing healthcare crisis and personalise treatment options for preventative care.
scientist in lab
February 25 2019
Results from a 62-patient follow-up study are due shortly, while data from a 500-person-strong managed access programme should be available by the end of next year
Surgery
February 20 2019
Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use